Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
| Image |  |
|---|---|
| Description | scientific article published on 08 May 2017 |
| Author/s |
author: emmanuel ndashimye Ann Sarah Walker Jennifer A Thompson Cissy Kityo Anne Hoppe Joep J van Oosterhout Philippa Easterbrook Andrew Kambugu Nicholas Iain Paton Peter Mugyenyi Immaculate Nankya Mary Kiconco Silvia Bertagnolio Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team |
| Publication date | May 8, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |